Literature DB >> 8228130

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

N Abuaf1, F Lunel, P Giral, E Borotto, S Laperche, R Poupon, P Opolon, J M Huraux, J C Homberg.   

Abstract

Recently antibodies to hepatitis C virus were detected in sera of chronic active hepatitis patients, with anti-smooth muscle autoantibodies or with anti-liver/kidney microsomal type 1 autoantibodies. As the latter were used to differentiate autoimmune chronic active hepatitis from chronic non-A, non-B virus hepatitis, it was mainly important to discover if autoantibodies were associated with chronic hepatitis C virus infection. The sera of 272 chronic hepatitis C patients were screened by indirect immunofluorescence for non-organ specific autoantibodies. Antinuclear antibodies and anti-smooth muscle autoantibodies were more frequent in chronic hepatitis C patients than in blood donors (n = 100). Anti-liver/kidney microsomal type 1 autoantibodies were not detected in the sera of the blood donors, in the 74 hepatitis B patients or in the 30 alcoholic hepatitis or cirrhotic patients' sera tested as controls. They were detected in 14 chronic hepatitis C patients. These antibodies were compared in immunodiffusion to anti-liver/kidney microsomal type 1 autoantibodies sera obtained from type-2 autoimmune chronic active hepatitis patients and an identity reaction was observed. Chronic hepatitis C patients without or with anti-liver/kidney microsomal type 1 autoantibodies, did not differ in age, sex ratio, transaminases and gammaglobulin level, risk factors for hepatitis C virus infection, association with other autoimmune diseases. These patients differed significantly from type-2 autoimmune chronic active hepatitis patients. We conclude that: (i) in some chronic hepatitis C patients the pattern and the titer of autoantibodies may create confusion with an autoimmune chronic active hepatitis; (ii) There is no serological evidence for a hepatitis C virus infection in true type-2 autoimmune chronic active hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228130     DOI: 10.1016/s0168-8278(05)80281-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome.

Authors:  J Ordi-Ros; J Villarreal; F Monegal; S Sauleda; I Esteban; M Vilardell
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA.

Authors:  Vincent Aubert; Isabelle Graf Pisler; François Spertini
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 4.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

5.  Performance parameters of the conventional serological markers for autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

6.  Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection.

Authors:  Y-Y Wu; T-C Hsu; T-Y Chen; T-C Liu; G-Y Liu; Y-J Lee; G J Tsay
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

7.  High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy.

Authors:  Giovanni Squadrito; Marcello Previti; Marco Lenzi; Enrico Pagano Le Rose; Gaia Caccamo; Tea Restuccia; Enrico Di Cesare; Teresa Pollicino; Giovanni Raimondo
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.

Authors:  G V Gregorio; K Choudhuri; Y Ma; P Pensati; R Iorio; P Grant; J Garson; D P Bogdanos; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody.

Authors:  Takashi Himoto; Seiji Nakai; Fumihiko Kinekawa; Hirohito Yoneyama; Akihiro Deguchi; Kazutaka Kurokochi; Tsutomu Masaki; Shoichi Senda; Reiji Haba; Seishiro Watanabe; Mikio Nishioka; Shigeki Kuriyama
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

10.  Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population.

Authors:  P Muratori; L Muratori; T Stroffolini; G Pappas; P Terlizzi; R Ferrari; S Loffreda; F Cassani; M Rapicetta; V Guadagnino; F B Bianchi; M Lenzi
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.